TMCnet News

Research and Markets: 2014 Opportunities in the US Infectious Disease Testing Market
[September 01, 2014]

Research and Markets: 2014 Opportunities in the US Infectious Disease Testing Market


DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/5jq957/2014) has announced the addition of the "2014 Opportunities in the US Infectious Disease Testing Market" report to their offering.

2014 Opportunities in the US Infectious Disease Testing Market is a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key US market trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests by assay, and market segment; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

Opportunities and Strategic Recommendations

  • Emerging opportunities for new instrumentation, reagents kits, IT and other products with significant market appeal during the next five years.
  • Design criteria for decentralized testing products.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.



Volume and sales forecasts for over 100 infectious disease assays by individual test and market segment:

  • Hospitals
  • Blood Banks
  • Commercial/Private Laboratories
  • Physician Offices/Group Practices
  • Public Health Laboratories
  • Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy).
  • Review of the market dynamics, trends, structure, size, growth and major suppliers.

Current and Emerging Products


  • In-depth examination of over 100 major diseases, including their etiology, current diagnostic tests, vaccines, drugs and market needs.
  • Review of major analyzers used for infectious disease testing, including their operating characteristics, features and selling prices.

Technology Review

  • Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for infectious disease testing.
  • Global listings of companies developing or marketing infectious disease diagnostic products by individual test.

Key Topics Covered:

I. Introduction

II. Major Product Development Opportunities

III. Design Criteria for Decentralized Testing Products

IV. Alternative Market Penetration Strategies

V. Potential Market Entry Barriers and Risks

VI. Worldwide Overview of Major Tests

Companies Mentioned

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher (News - Alert)
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Enzo Biochem
  • Fujirebio/Innogenetics
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Kreatech
  • Life Technology
  • Lonza
  • Nanogen/Elitech
  • Novartis Diagnostics
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens (News - Alert)
  • Takara Bio
  • Thermo Fisher
  • Wallac/PE
  • Wako

For more information visit http://www.researchandmarkets.com/research/5jq957/2014


[ Back To TMCnet.com's Homepage ]